Technology-enabled clinical research company

IPO:
IPO 2021 (NASDAQ: SNCE)
Investors:
Amgen Ventures, dRx Capital, Glynn Capital Management, GV, Lux Capital, Redmile Group, Sanofi-Genzyme BioVenures